In ₹ Crore except Per Share Latest Annual | INDRAMEDCO FY26 | ARTEMISMED FY26 | SHALBY FY26 | GKSL FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 18.00× | 52.90× | 44.97× | 69.84× | 52.90× -66% | |
| P/B | 4.46× | 5.84× | ◆ 1.55× | 5.38× | 5.38× -17% | |
| EV/EBITDA | ◆ 12.36× | 30.22× | 14.13× | 50.98× | 30.22× -59% | |
| Market Cap | ₹3,305 Cr | ₹5,493 Cr | ₹1,562 Cr | ₹1,371 Cr | ₹1,562 Cr +112% | |
| Growth | ||||||
| Revenue CAGR 3Y | 10.50% | ◆ 13.61% | 12.35% | — | 12.98% -19% | |
| Revenue CAGR 5Y | 19.30% | ◆ 21.50% | — | — | 21.50% -10% | |
| Net Income CAGR 3Y | 28.69% | ◆ 39.74% | -19.97% | — | 9.89% +190% | |
| Revenue YoY (latest Q) | 11.26% | ◆ 12.69% | 11.74% | — | 12.21% -8% | |
| Net Income YoY (latest Q) | 8.53% | ◆ 48.33% | 36.70% | — | 42.52% -80% | |
| Profitability | ||||||
| EBITDA Margin | 18.00% | 17.40% | 12.51% | ◆ 32.85% | 17.40% +3% | |
| Net Income Margin | 12.39% | 9.59% | 3.04% | ◆ 20.50% | 9.59% +29% | |
| Return on Common Equity | ◆ 24.80% | 11.02% | 3.72% | 6.08% | 6.08% +308% | |
| Return on Capital Employed | ◆ 27.17% | 11.50% | 5.76% | 8.24% | 8.24% +230% | |
| Return on Assets | ◆ 18.52% | 7.26% | 1.89% | 5.65% | 5.65% +228% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.24× | 0.54× | 0.06× | 0.24× -100% | |
| Interest Coverage | ◆ 37.09× | 5.06× | 1.87× | 11.84× | 5.06× +633% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,483 Cr | ₹1,081 Cr | ₹1,141 Cr | ₹82 Cr | ₹1,081 Cr +37% | |
| Net Income | ₹184 Cr | ₹104 Cr | ₹34.7 Cr | ₹16.8 Cr | ₹34.7 Cr +429% | |
| Total Assets | ₹991 Cr | ₹1,429 Cr | ₹1,839 Cr | ₹298 Cr | ₹1,429 Cr -31% | |
| EPS | ₹20.03 | ₹6.56 | ₹3.23 | ₹2.49 | ₹3.23 +520% | |
| Book Value per Share | ₹80.76 | ₹59.42 | ₹93.54 | ₹32.31 | ₹59.42 +36% | |